Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;44:27-28
Published online before print June 14, 2004, doi: 10.1161/01.HYP.0000134531.28796.32
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
44/1/27    most recent
01.HYP.0000134531.28796.32v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geller, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geller, D. S.
Related Collections
Right arrow Other hypertension
Right arrow Genetics of cardiovascular disease

(Hypertension. 2004;44:27.)
© 2004 American Heart Association, Inc.


Editorial Commentaries

A Genetic Predisposition to Hypertension?

David S. Geller

From the Section of Nephrology, Yale University School of Medicine, New Haven, Conn.

Correspondence to David S. Geller, PO Box 208029, New Haven, CT 06520-8029. E-mail david.geller@yale.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Hypertension is a majorpublic health problem, and yet, the molecular mechanisms underlying hypertension are poorly understood in the majority of patients. A complex disorder, both environmental and genetic factors predispose individuals to hypertension. Whereas we know much about environmental factors, such as salt intake and exercise, that affect blood pressure, we know less about genetic factors that predispose individuals to hypertension. In recent years, there has been great progress in elucidating the molecular basis of monogenic disorders with primary effect on blood pressure, and this work has clarified many aspects of blood pressure regulation.1 Among the most significant findings from this work has been that all known single-gene disorders with primary effect on blood pressure act via a single final common pathway-alteration of renal sodium reabsorption. These studies mirror what has been observed in acquired forms of hypertension, which uniformly feature increased sodium reabsorption as well. The sum of these findings is consistent with a large body of physiological work and animal studies drawing on the pioneering work of Arthur Guyton, who proposed that sustained hypertension ultimately required the active participation of the kidney.2 The finding that all known inherited and acquired forms of hypertension ultimately operate via the same common pathway has led to the proposal that common forms of hypertension will feature perturbations in this pathway as well.1

Although such work has greatly expanded our understanding of molecular mechanisms underlying hypertension, pathways determining this genetic predisposition to hypertension in the general population remain unknown. In recent years, there . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
T. J. Jentsch
Chloride Transport in the Kidney: Lessons from Human Disease and Knockout Mice
J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1549 - 1561.
[Abstract] [Full Text] [PDF]